Orbis Biosciences

Orbis Biosciences, Inc. specializes in developing controlled-release delivery systems applicable across various sectors, including pharmaceuticals, consumer products, chemicals, and food and beverage industries. Established in 2007 and based in Lenexa, Kansas, the company utilizes precision particle fabrication technology to allow businesses to innovate and enhance their product offerings by controlling critical particle parameters such as size, encapsulation material, shell thickness, and porosity. This scalability enables Orbis Biosciences to provide tailored solutions for a diverse range of applications, from drug formulations to agricultural compounds and novel food processing techniques. The company's technologies focus on creating uniform microspheres and microcapsules, optimizing both oral and injectable pharmaceutical products through customized drug release and format flexibility, ultimately improving compliance for end users. As of April 30, 2020, Orbis operates as a subsidiary of Adare Pharmaceuticals, Inc.